Antiviral agent
All relevant publications
Antiviral agent
Published by
Wenshi Wang
Hepatitis E virus (HEV) infection can cause severe complications and high mortality in pregnant women, organ transplant recipients, patients with pre-existing liver disease and immunosuppressed patien...
Hepatitis E virus (HEV) infection can cause severe complications and high mortality in pregnant women, organ transplant recipients, patients with pre-existing liver disease and immunosuppressed patien...
Antiviral agent
Published by
Mohammad Khalid Parvez
In the absence of a globally accessible HEV vaccine, peg-IFNα-2a and ribavirin are the only effective regimen of choice for acute hepatic failure and chronic hepatitis E. However, though ribavirin in...
In the absence of a globally accessible HEV vaccine, peg-IFNα-2a and ribavirin are the only effective regimen of choice for acute hepatic failure and chronic hepatitis E. However, though ribavirin in...
Antiviral agent
Published by
Mohammad Khalid Parvez
Globally, pegylated interferon-α and ribavirin are the only recommended antiviral agents for treating chronic hepatitis E patients. However, though ribavirin induces a sustained virologic response, s...
Globally, pegylated interferon-α and ribavirin are the only recommended antiviral agents for treating chronic hepatitis E patients. However, though ribavirin induces a sustained virologic response, s...
Antiviral agent
Published by
Yunlong Li
On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treating hepatitis E virus (HEV) infection at Erasmus University Rotterdam, the Netherlands. ...
On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treating hepatitis E virus (HEV) infection at Erasmus University Rotterdam, the Netherlands. ...
Antiviral agent
Published by
Mohammad Khalid Parvez
HEV has been recognized with eight genotypes (HEV1- HEV8), of which HEV1-HEV4 are infectious to humans. While HEV1 is waterborne infection causing self-limiting acute hepatitis E in general population...
HEV has been recognized with eight genotypes (HEV1- HEV8), of which HEV1-HEV4 are infectious to humans. While HEV1 is waterborne infection causing self-limiting acute hepatitis E in general population...
Antiviral agent
Published by
Mara Klöhn, Eike Steinmann
Every year, an estimated 20 million people become infected with HEV, resulting in 3.3 million acute cases and approximately 70,000 deaths annually, making HEV the leading cause for acute viral hepatit...
Every year, an estimated 20 million people become infected with HEV, resulting in 3.3 million acute cases and approximately 70,000 deaths annually, making HEV the leading cause for acute viral hepatit...
0 - 6 of 6 items
EVENTS
2023-04-28
2nd International HEV Symposium
The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. More information: https://www.ivi.int/hev-symposium-2023/
The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. More information: https://www.ivi.int/hev-symposium-2023/
